FRONT PAGE AMPYRA AUBAGIO AVONEX BETASERON COPAXONE EXTAVIA
Stan's Angels MS News Channel on YouTube GILENYA NOVANTRONE REBIF RITUXAN TECFIDERA TYSABRI
 Daily News for Neuros, Nurses & Savvy MSers: 208,152 Viewers, 8,368 Stories & Studies
Click Here For My Videos, Advice, Tips, Studies and Trials.
Timothy L. Vollmer, MD
Department of Neurology
University of Colorado Health Sciences Center Professor

Co-Director of the RMMSC at Anschutz Medical Center

Medical Director-Rocky Mountain MS Center
Click here to read my columns
Brian R. Apatoff, MD, PhD
Multiple Sclerosis Institute
Center for Neurological Disorders

Associate Professor Neurology and Neuroscience,

Weill Medical College of Cornell University

Clinical Attending in Neurology,
New York-Presbyterian Hospital
CLICK ON THE RED BUTTON BELOW
You'll get FREE Breaking News Alerts on new MS treatments as they are approved
MS NEWS ARCHIVES: by week

HERE'S A FEW OF OUR 6000+ Facebook & MySpace FRIENDS
Timothy L. Vollmer M.D.
Department of Neurology
University of Colorado Health Sciences Center
Co-Director of the RMMSC at Anschutz Medical Center
and
Medical Director-Rocky Mountain MS Center


Click to view 1280 MS Walk photos!

"MS Can Not
Rob You of Joy"
"I'm an M.D....my Mom has MS and we have a message for everyone."
- Jennifer Hartmark-Hill MD
Beverly Dean

"I've had MS for 2 years...this is the most important advice you'll ever hear."
"This is how I give myself a painless injection."
Heather Johnson

"A helpful tip for newly diagnosed MS patients."
"Important advice on choosing MS medication "
Joyce Moore


This page is powered by Blogger. Isn't yours?

Tuesday

 

Is Ocrevus (Ocrelizumab) Right for Me? So Close, Yet So Far





















History has been made because of a major breakthrough for MS sufferers everywhere. Ocrevus (ocrelizumab) by Genentech has been finally approved by the U.S. Food and Drug Administration. It is the first drug treatment that includes my type of MS, primary progressive. This is what I’ve been waiting for. It’s groundbreaking, innovative and hopeful — but is it right for me?

Don’t get me wrong, I am excited, even ecstatic. I feel PPMS is no longer the child left out of the game, that those of us with this rare type of MS are not ignored! I am hopeful, but at the same time I am apprehensive. Will the possibility of slowing my MS progression come with a price — possibly that of adding more health concerns to my already full plate?

According to a statement from one of the nation’s leading MS clinics, the International Multiple Sclerosis Management Practice (IMSMP), they say there are “some serious concerns” when deciding whether to use Ocrevus as your MS treatment plan.

The optimistic side is a possible 25 percent decrease in progression with use of the drug for PPMS patients, and an even better decrease is possible for relapsing remitting forms of MS.

However, I remain cautions because during clinical trials of Ocrevus, there was evidence of cancer and serious infections.

I have read of some promising results for younger patients, but for older patients such as myself, not so much. I have searched to find the criteria to be considered for Ocrevus treatment, and there’s not much of it on the Internet.

I may be fretting over this decision without reason. The decision may have already been made for me. So I will wait to talk to my neurologist and see if I meet the criteria for treatment with Ocrevus.

My situation is that I was diagnosed with PPMS in 2010, and I am over 55 years old. I walk with assistance for short distances and use a manual wheelchair for longer excursions. I have been on the high dose biotin protocol for one year with some noted improvement.

Story Source: The above story is based on materials provided by MULTIPLESCLEROSISNEWSTODAY
Note: Materials may be edited for content and length
Click here to read more

Labels: , , ,



Go to Newer News Go to Older News